Charles J Casamento's Net Worth

$2.31 Million

Estimate Recalculated Nov 1, 2024 10:49AM EST

Who is Charles J Casamento

Charles J Casamento has an estimated net worth of $2.31 Million. This is based on reported shares across multiple companies, which include PaxMedica, Inc., CORTEX PHARMACEUTICALS INC/DE/, Osteologix, Inc., International Stem Cell CORP, RELMADA THERAPEUTICS, INC., Eton Pharmaceuticals, Inc., First Wave BioPharma, Inc., GT Biopharma, Inc., VIVUS INC, and Astex Pharmaceuticals, Inc.

SEC CIK

Charles J Casamento's CIK is 0001117167

Past Insider Trading and Trends

2012 was Charles J Casamento's most active year for acquiring shares with 16 total transactions. Charles J Casamento's most active month to acquire stocks was the month of May. 2013 was Charles J Casamento's most active year for disposing of shares, totalling 23 transactions. Charles J Casamento's most active month to dispose stocks was the month of February. 2019 saw Charles J Casamento paying a total of $5,759,210.51 for 773,578 shares, this is the most they've acquired in one year. In 2012 Charles J Casamento cashed out on 262,000 shares for a total of $910,277.00, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PaxMedica, Inc.

Investor

Updated Mar 14, 2024

View Quote Details


Form 4	-29.37%	-992.00	$0.69	-$684.48	Mar 14, 2024	2.39K	Tax	—	Mar 12
Form 4	-2.79%	-97.00	$0.76	-$73.72	Jan 31, 2024	3.38K	Tax	—	Jan 29
Form 4	-9.97%	-6.54K	$0.29	-$1.87K	Oct 04, 2023	59.05K	Tax	—	Oct 02
Form 4	27.14%	14.00K	—	—	Apr 14, 2023	65.58K	Grant	—	Apr 13
Form 4	—	51.58K	—	—	Oct 04, 2022	51.58K	Grant	—	Oct 01
Form 3	—	—	—	—	Oct 04, 2022	—	—	—	—

Showing 6 results

CORTEX PHARMACEUTICALS INC/DE/

Investor

Updated Aug 07, 2012

View Quote Details


Form 4	—	376.67K	—	—	Aug 07, 2012	376.67K	Grant	—	Aug 03
Form 4	—	30.00K	—	—	Mar 03, 2011	30.00K	Grant	—	Mar 01
Form 4	—	30.00K	—	—	Mar 04, 2010	30.00K	Grant	—	Mar 03
Form 4	—	30.00K	—	—	Aug 24, 2009	30.00K	Grant	—	Aug 22
Form 4	—	30.00K	—	—	Jun 08, 2009	30.00K	Grant	—	Jun 05
Form 4	—	30.00K	—	—	Feb 13, 2008	30.00K	Grant	—	Feb 13
Form 4	—	15.00K	$0.50	$7.50K	Nov 30, 2007	15.00K	Purchase	—	Nov 30
Form 4	—	25.00K	—	—	Feb 07, 2007	25.00K	Grant	—	Feb 06
Form 4	-100.00%	-17.65K	—	—	Jan 30, 2006	—	Grant	—	Feb 08 - Feb 10
Form 4	—	25.00K	—	—	Dec 05, 2005	25.00K	Grant	—	Dec 01
Form 4	16.50%	2.50K	$0.70	$12.36K	Feb 09, 2005	17.65K	Purchase	—	Feb 08 - Feb 09
Form 4	—	25.00K	—	—	Dec 16, 2004	25.00K	Grant	—	Dec 16
Form 4	—	25.00K	—	—	Dec 10, 2003	25.00K	Grant	—	Dec 09

Showing 13 results

Osteologix, Inc.

CEO & President

Updated Oct 10, 2006


Form 4	—	350.00K	$1.20	$420.00K	Oct 10, 2006	350.00K	Grant	—	Oct 05
Form 3	—	—	—	—	May 26, 2006	57.42K	—	—	—

Showing 2 results

International Stem Cell CORP

Investor

Updated Jun 25, 2018

View Quote Details


Form 4	42.84%	4.33K	—	—	Jun 25, 2018	14.43K	Grant	—	Jun 21
Form 4	-54.86%	-12.28K	—	—	May 16, 2018	10.10K	Grant	—	May 16
Form 4	32.79%	5.53K	—	—	Apr 04, 2018	22.38K	Grant	—	Mar 30
Form 4	-66.86%	-34.00K	—	—	Feb 01, 2018	16.86K	Grant	—	Jan 09
Form 4	11.33%	5.17K	—	—	Jan 02, 2018	50.86K	Grant	—	Dec 29
Form 4	10.70%	4.42K	—	—	Oct 02, 2017	45.68K	Grant	—	Sep 29
Form 4	20.88%	7.13K	—	—	Jul 05, 2017	41.27K	Grant	—	Jun 30
Form 4	—	30.00K	—	—	Jun 02, 2017	30.00K	Grant	—	May 31
Form 4	15.74%	4.64K	—	—	Apr 03, 2017	34.14K	Grant	—	Mar 31
Form 4	34.24%	7.52K	—	—	Dec 30, 2016	29.50K	Grant	—	Dec 30
Form 4	6.46%	1.33K	—	—	Oct 14, 2016	21.97K	Grant	—	Oct 13
Form 4	27.02%	4.39K	—	—	Sep 30, 2016	20.64K	Grant	—	Sep 30
Form 4	33.11%	4.04K	—	—	Jun 30, 2016	16.25K	Grant	—	Jun 30
Form 4	-50.00%	-30.00K	—	—	May 18, 2016	30.00K	Grant	—	May 17
Form 4	20.83%	2.10K	—	—	Apr 04, 2016	12.21K	Grant	—	Mar 31
Form 4	31.21%	2.40K	—	—	Dec 31, 2015	10.10K	Grant	—	Dec 31
Form 4	35.35%	2.01K	—	—	Oct 02, 2015	7.70K	Grant	—	Sep 30
Form 4	27.07%	181.77K	—	—	Jul 02, 2015	853.34K	Grant	—	Jun 30
Form 4	17.48%	99.95K	—	—	Apr 08, 2015	671.58K	Grant	—	Apr 08
Form 4	15.56%	76.96K	—	—	Mar 23, 2015	571.61K	Grant	—	Mar 06
Form 4	11.16%	49.65K	—	—	Oct 02, 2014	494.65K	Grant	—	Oct 02
Form 4	9.88%	40.00K	—	—	May 12, 2014	445.00K	Grant	—	May 08
Form 4	67.01%	162.50K	—	—	Mar 25, 2014	405.00K	Grant	—	Mar 21
Form 4	19.75%	40.00K	—	—	Jun 21, 2013	242.50K	Grant	—	Jun 20
Form 4	406.25%	162.50K	—	—	Jan 29, 2013	202.50K	Grant	—	Jan 25
Form 4	—	40.00K	—	—	May 31, 2012	40.00K	Grant	—	May 29
Form 4	—	50.00K	—	—	May 04, 2011	50.00K	Grant	—	May 03
Form 4	—	50.00K	—	—	Jan 14, 2011	50.00K	Grant	—	Jan 13
Form 4	—	50.00K	—	—	Jun 22, 2010	50.00K	Grant	—	Jun 21
Form 3	—	—	—	—	Jun 22, 2010	—	—	—	—

Showing 30 results

RELMADA THERAPEUTICS, INC.

Investor

Updated Oct 23, 2024

View Quote Details


Form 4	-100.00%	-13.00K	—	—	Oct 23, 2024	—	Grant	—	Oct 22
Form 4	—	13.00K	$2.56	$33.28K	Sep 11, 2024	13.00K	Purchase	—	Sep 09
Form 4	—	—	—	—	May 29, 2024	31.52K	Acq/Dis	—	May 24
Form 4	—	31.52K	—	—	Dec 19, 2023	31.52K	Grant	—	Dec 15
Form 4	162.96%	92.96K	—	—	May 30, 2023	150.00K	Grant	—	May 25
Form 4	—	57.04K	—	—	Dec 20, 2022	57.04K	Grant	—	Dec 16
Form 4	155.25%	91.23K	—	—	May 26, 2022	150.00K	Grant	—	May 25
Form 4	34.31%	19.80K	$16.12	-$510.05K	Apr 05, 2022	77.51K	Sell-Options	Scheduled	Apr 01
Form 4	—	58.77K	—	—	Dec 21, 2021	58.77K	Grant	—	Dec 17
Form 4	1.42%	1.50K	$16.80	-$145.40K	Sep 24, 2021	107.31K	Sell-Options	Scheduled	Sep 22
Form 4	—	—	$4.60	$46.00K	Aug 19, 2021	117.20K	Options	—	Aug 17
Form 4	-23.82%	-3.30K	$31.76	-$104.09K	Jul 16, 2021	10.55K	Sale	Scheduled	Jul 15
Form 4/A	—	—	—	—	Jun 22, 2021	62.53K	—	—	—
Form 4	-30.15%	-3.00K	$33.34	-$100.02K	Jun 02, 2021	6.95K	Sale	Scheduled	Jun 01
Form 4	-23.17%	-3.00K	$38.22	-$114.65K	May 05, 2021	9.95K	Sale	Scheduled	May 03
Form 4	-18.81%	-3.00K	$35.43	-$106.28K	Apr 05, 2021	12.95K	Sale	Scheduled	Apr 01
Form 4	-15.83%	-3.00K	$33.87	-$101.62K	Mar 02, 2021	15.95K	Sale	Scheduled	Mar 01
Form 4	-13.67%	-3.00K	$33.63	-$100.90K	Feb 02, 2021	18.95K	Sale	Scheduled	Feb 01
Form 4	—	100.00K	—	—	Jan 11, 2021	100.00K	Grant	—	Jan 07
Form 4	-12.02%	-3.00K	$32.11	-$96.34K	Jan 05, 2021	21.95K	Sale	Scheduled	Jan 04
Form 4	-49.26%	-24.22K	$35.74	-$107.22K	Dec 02, 2020	24.95K	Sale	Scheduled	Nov 24 - Dec 01
Form 4	-5.75%	-3.00K	$30.29	-$90.86K	Nov 03, 2020	49.17K	Sale	Scheduled	Nov 02
Form 4	-5.44%	-3.00K	$37.99	-$113.96K	Oct 02, 2020	52.17K	Sale	Scheduled	Oct 01
Form 4	-5.16%	-3.00K	$34.74	-$104.21K	Sep 02, 2020	76.66K	Sale	Scheduled	Sep 01
Form 4	-2.33%	-2.19K	$21.14	-$23.79	Aug 19, 2020	113.06K	Options	—	Aug 18
Form 4	-8.11%	-3.00K	$35.74	-$107.21K	Aug 04, 2020	55.48K	Sale	Scheduled	Aug 03
Form 4	-7.50%	-3.00K	$43.89	-$131.68K	Jul 02, 2020	58.48K	Sale	Scheduled	Jul 01
Form 4	—	—	—	—	Mar 18, 2020	61.48K	Grant	—	Mar 17
Form 4	-2.79%	-6.09K	$22.15	-$19.60	Dec 27, 2019	212.66K	Options	—	Dec 24
Form 4	—	100.00K	$43.47	$4.35M	Dec 23, 2019	100.00K	Grant	—	Dec 19
Form 4	—	500.00K	$2.20	$1.10M	Jul 30, 2019	500.00K	Grant	—	Jul 29
Form 4	—	450.00K	$1.15	$517.50K	Dec 20, 2018	450.00K	Grant	—	Dec 20
Form 4	—	425.00K	$0.81	$344.25K	Oct 23, 2017	425.00K	Grant	—	Oct 20
Form 4	—	4.20K	$2.97	$12.46K	Dec 16, 2015	4.20K	Purchase	—	Dec 14
Form 3	—	—	—	—	Jul 16, 2015	—	—	—	—

Showing 35 results

Eton Pharmaceuticals, Inc.

Investor

Updated Feb 15, 2024

View Quote Details


Form 4	22.30%	30.00K	—	—	Feb 15, 2024	164.56K	Grant	—	Feb 13
Form 4	22.82%	25.00K	—	—	Mar 03, 2023	134.56K	Grant	—	Mar 03
Form 4	83.96%	50.00K	—	—	Feb 28, 2022	109.56K	Grant	—	Feb 07
Form 4	49.26%	19.66K	—	—	May 05, 2021	59.56K	Grant	—	May 03
Form 4	—	27.40K	—	—	Mar 16, 2020	27.40K	Grant	—	Mar 12
Form 4	5.12%	3.50K	$6.11	$21.37K	Aug 12, 2019	71.92K	Purchase	—	Aug 09
Form 4	—	12.50K	—	—	Mar 08, 2019	12.50K	Grant	—	Feb 20
Form 4	9.04%	5.67K	$6.00	—	Nov 15, 2018	68.42K	Purchase	—	Nov 15
Form 3	—	—	—	—	Nov 13, 2018	54.75K	—	—	—

Showing 9 results

First Wave BioPharma, Inc.

Investor

Updated Jan 04, 2024

View Quote Details


Form 4	6,458.22%	19.63K	—	—	Jan 04, 2024	19.94K	Grant	—	Jan 02
Form 4	-0.16%	-10.00	$0.43	-$4.30	Sep 18, 2023	6.10K	Sale	—	Sep 15
Form 4	-49.77%	-6.05K	$0.30	-$1.82K	Sep 05, 2023	6.11K	Sale	—	Aug 31
Form 4	21,785.35%	84.75K	—	—	Jan 05, 2023	85.13K	Grant	—	Jan 03
Form 4	—	34.48K	—	—	Jan 03, 2022	34.48K	Grant	—	Jan 03
Form 4	—	41.24K	—	—	Jan 06, 2021	41.24K	Grant	—	Jan 04
Form 4	—	80.00K	—	—	Apr 07, 2020	80.00K	Grant	—	Apr 06
Form 4	—	—	—	—	Mar 23, 2020	225.00K	Grant	—	Mar 19
Form 4	24.47%	23.00K	$0.76	$17.50K	Mar 13, 2020	117.00K	Grant	—	Mar 11
Form 4	8.67%	7.50K	$1.04	$7.80K	Jan 03, 2020	94.00K	Grant	—	Dec 31
Form 4	9.49%	7.50K	$0.60	$4.50K	Oct 01, 2019	86.50K	Grant	—	Sep 30
Form 4	10.49%	7.50K	$1.70	$12.75K	Jul 02, 2019	79.00K	Grant	—	Jun 30
Form 4/A	—	30.00K	—	—	Jun 21, 2019	30.00K	Grant	—	Jun 13
Form 4	41.96%	30.00K	—	—	Jun 17, 2019	101.50K	Grant	—	Jun 13
Form 4	11.72%	7.50K	$2.42	$18.15K	Apr 29, 2019	71.50K	Grant	—	Mar 31
Form 4	34.74%	16.50K	$1.36	$22.37K	Jan 02, 2019	64.00K	Purchase	—	Dec 28
Form 4	18.75%	7.50K	$2.57	$19.28K	Oct 01, 2018	47.50K	Grant	—	Sep 28
Form 4	23.08%	7.50K	—	—	Jul 16, 2018	40.00K	Grant	—	Jun 29
Form 4	30.00%	7.50K	$3.14	$23.55K	Apr 02, 2018	32.50K	Grant	—	Mar 29
Form 4	—	17.50K	—	—	Oct 23, 2017	17.50K	Grant	—	Oct 19
Form 3	—	—	—	—	Mar 09, 2017	—	—	—	—

Showing 21 results

GT Biopharma, Inc.

Investor

Updated Jun 21, 2023

View Quote Details


Form 4	—	500.00K	—	—	Jun 21, 2023	500.00K	Grant	—	Jun 16
Form 3	—	—	—	—	May 04, 2023	—	—	—	—

Showing 2 results

VIVUS INC

Investor

Updated Apr 22, 2013


Form 4	-70.01%	-61.00K	—	—	Apr 22, 2013	26.13K	Grant	—	Dec 14 - Apr 05
Form 4	32.01%	21.13K	—	—	Jan 29, 2013	87.13K	Grant	—	Jan 25
Form 4	-10.81%	-8.00K	$13.16	-$119.54K	Aug 21, 2012	66.00K	Sale	—	Aug 20
Form 4	8.20%	5.00K	—	—	Jun 19, 2012	66.00K	Grant	—	Jun 15
Form 4	-37.76%	-37.00K	$14.51	-$416.76K	Mar 13, 2012	61.00K	Sale	—	Mar 12
Form 4	—	—	$6.00	$216.04K	Feb 28, 2012	73.00K	Options	—	Feb 27
Form 4	—	25.00K	—	—	Jan 31, 2012	25.00K	Grant	—	Jan 27
Form 4	—	—	$4.23	$105.75K	Dec 08, 2011	25.00K	Options	—	Dec 06
Form 4	—	8.00K	—	—	Jun 20, 2011	8.00K	Grant	—	Jun 17
Form 4	—	25.00K	—	—	Jan 25, 2011	25.00K	Grant	—	Jan 21
Form 4	—	8.00K	—	—	Jun 28, 2010	8.00K	Grant	—	Jun 25
Form 4	—	25.00K	—	—	Jan 26, 2010	25.00K	Grant	—	Jan 22
Form 4	—	8.00K	—	—	Jun 30, 2009	8.00K	Grant	—	Jun 26
Form 4	—	25.00K	—	—	Jan 27, 2009	25.00K	Grant	—	Jan 23
Form 4	—	32.00K	—	—	Apr 21, 2008	32.00K	Grant	—	Apr 17
Form 3	—	—	—	—	Apr 21, 2008	—	—	—	—

Showing 16 results

Astex Pharmaceuticals, Inc

Investor

Updated Oct 16, 2013


Form 4	-100.00%	-180.83K	—	—	Oct 16, 2013	—	Disposition	—	Oct 01 - Oct 11
Form 4	—	32.50K	—	—	Jun 17, 2013	32.50K	Grant	—	Jun 13
Form 4	-100.00%	-71.00K	$4.37	-$213.78K	May 07, 2013	—	Sale	—	May 03
Form 4	-100.00%	-30.00K	—	—	Apr 16, 2013	—	Grant	—	Apr 12
Form 4	—	—	$2.01	$20.10K	Apr 05, 2013	30.00K	Options	—	Apr 03
Form 4	—	—	$1.98	$19.80K	Apr 03, 2013	20.00K	Options	—	Apr 02
Form 4	—	—	$1.98	$19.80K	Mar 29, 2013	10.00K	Options	—	Mar 28
Form 4	-100.00%	-14.00K	$3.37	-$25.34K	Mar 15, 2013	—	Sale	—	Mar 13
Form 4	-100.00%	-50.00K	—	—	Feb 21, 2013	—	Grant	—	Sep 17
Form 4	—	—	$2.76	$138.00K	Sep 10, 2012	50.00K	Options	—	Sep 06
Form 4	—	32.50K	—	—	Jun 26, 2012	32.50K	Grant	—	Jun 22
Form 4	—	25.83K	—	—	Jun 16, 2011	25.83K	Grant	—	Jun 16
Form 4	—	35.00K	—	—	Jun 14, 2010	35.00K	Grant	—	Jun 10
Form 4	—	7.50K	—	—	Sep 21, 2009	7.50K	Grant	—	Sep 17
Form 4	—	20.00K	—	—	Jun 15, 2009	20.00K	Grant	—	Jun 11
Form 4	—	20.00K	—	—	Jun 16, 2008	20.00K	Grant	—	Jun 12
Form 4	—	20.00K	—	—	Jun 18, 2007	20.00K	Grant	—	Jun 14
Form 4	—	20.00K	—	—	Jun 13, 2006	20.00K	Grant	—	Jun 09
Form 4	—	—	$2.76	$69.00K	Aug 09, 2005	50.00K	Options	—	Aug 05
Form 4	—	15.00K	—	—	May 16, 2005	15.00K	Grant	—	May 12
Form 4	—	10.00K	—	—	Oct 08, 2004	10.00K	Grant	—	Oct 06
Form 4	—	15.00K	—	—	May 10, 2004	15.00K	Grant	—	May 06

Showing 22 results